Amedica acquires US Spine; AgaMatrix, Sanofi launch glucose monitoring devce for iPhone

> Amedica Corporation, a spinal and orthopaedic implant and instrument company, has acquired US Spine, a privately held medical device company focused on the development and commercialization of advanced spinal implant systems. Amedica release

> AgaMatrix, a Salem, NH-based maker of blood glucose-monitoring products, and its Paris partner Sanofi-aventis have launched blood glucose monitoring devices BGStar and iBGStar that connect to the Apple iPhone or iPod touch. News

> Volcano has accused rival St. Jude Medical of patent fraud in the latest round of a legal war over technology designed to measure arterial blood pressure. Article

> Aethlon Medical has reestablished efforts to advance the Aethlon Hemopurifier within U.S. Government programs that support the development and purchase of treatment countermeasures against bioterror threats. Aethlon release

> Dgimed Ortho is looking to raise $2 million from the sale of equity and warrants, according to documents filed with the Securities and Exchange Commission. Article

>  Vycor Medical a medical device company that designs, develops and markets next generation neurosurgery retraction devices, today announced the appointment of a National Sales Director. Tom Bridges is a veteran sales and marketing executive with over 28 years of experience in the medical device industry. Vycor release

> St. Jude Medical has announced subset data results for the Angio-Seal Evolution Vascular Closure Device Registry. The results reaffirm the excellent sealing performance of the Angio-Seal Evolution vascular closure device in patients undergoing routine diagnostic and interventional cardiac catheterization procedures. St. Jude release

> The Pittsburgh Life Sciences Greenhouse (PLSG), the organization providing capital investments and customized company formation and business growth programs to western Pennsylvania's life sciences enterprises, announced today that one of its nationally recognized Executives-in-Residence (EIR) has launched a new medical device company; Intimate Bridge to Conception, Inc. (Ib2C). PLSG release

> ConTIPI has been acquired by Procter & Gamble for $100 million. The start-up, which develops disposable vaginal devices that reduce or prevent urinary incontinence, has signed an agreement to be sold which will be implemented in stages. Article

> Pyng Medical has announced the resignation of current president and CEO, Robert Di Silvio, effective Sept. 30. Pyng's board of directors has appointed Mark Hodge as interim president and CEO, effective Oct. 1. Pyng release

And Finally... Researchers may be on the verge of figuring out a way to power pacemakers with energy sources from a person's own body. Scientists have successfully tested out a biofuel cell that is fueled by the body's blood sugar and oxygen--a resource abundant in human bodies. To test this new system, the Université Joseph Fourier in Grenoble, France researchers implanted the biofuel cell into a rat. Article

Suggested Articles

Takeda tapped Roche’s Foundation Medicine to develop tissue- and blood-based companion diagnostic tests for its portfolio of lung cancer therapies.

Cellex has announced plans to develop a rapid coronavirus test that people can fully perform at home, from sample collection to result, using an app.

More than 20 states either don’t release or have incomplete data on the rapid antigen tests now considered key to containing the coronavirus.